{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:00:06Z","timestamp":1787162406736,"version":"build-2736575974"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"23","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The von Hippel-Lindau (VHL) disease is caused by VHL germ line mutation. Inactivation of the wild-type copy of the VHL gene leads to up-regulation of hypoxic response and tumor formation within central nervous system (CNS), kidneys, pancreas, adrenal glands, epididymis, broad ligament, and the endolymphatic sac\/petrous bone. Endolymphatic sac tumors (ELST) have been proposed to be derived from endolymphatic sac epithelium, but other possible structures of origin have been implicated. To clarify the anatomic and cellular origin of ELSTs, we did a morphologic and molecular pathologic analysis of 16 tumors. In addition, we investigated effects of VHL deficiency on \u201ctumor-free\u201d endolymphatic duct and sac of VHL patients. Several tumors included in this study were &amp;lt;1 cm in size, and their origin could be placed in the intraosseous portion of the endolymphatic duct\/sac. Furthermore, by analysis of clinically uninvolved \u201ctumor-free\u201d endolymphatic duct and sac tissues of VHL patients, we discovered a variety of VHL-deficient microscopic abnormalities with morphologic similarities to ELSTs. We conclude that most, if not all, ELSTs arise within the intraosseous portion of the endolymphatic duct\/sac, the vestibular aqueduct. In analogy to renal parenchyma and selected topographical sites within the CNS, endolymphatic duct\/sac epithelia are preferentially and multifocally targeted in VHL disease. The primary effect of VHL deficiency on human endolymphatic duct\/sac epithelium seems to be the generation of multifocal sites of VHL-deficient cell proliferations from which tumorigenesis may or may not occur. Therefore, inactivation of the VHL wild-type allele seems necessary but not sufficient for the formation of tumor.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-1104","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T15:48:14Z","timestamp":1133452094000},"page":"10847-10853","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effects of\n                    <i>VHL<\/i>\n                    Deficiency on Endolymphatic Duct and Sac"],"prefix":"10.1158","volume":"65","author":[{"given":"Sven","family":"Gla\u0308sker","sequence":"first","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Lonser","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine G.B.","family":"Tran","sequence":"additional","affiliation":[{"name":"3Renal Section, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ikejiri","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Butman","sequence":"additional","affiliation":[{"name":"2Diagnostic Radiology Department, Warren G. Magnuson Clinical Center, NIH, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifen","family":"Zeng","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"3Renal Section, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Oldfield","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander O.","family":"Vortmeyer","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,12,1]]},"reference":[{"key":"2022061621195747300_B1","doi-asserted-by":"crossref","unstructured":"Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer\u20081989; 64: 2292\u2013302.","DOI":"10.1002\/1097-0142(19891201)64:11<2292::AID-CNCR2820641119>3.0.CO;2-#"},{"key":"2022061621195747300_B2","doi-asserted-by":"crossref","unstructured":"Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA\u20081997; 277: 1461\u20136.","DOI":"10.1001\/jama.277.18.1461"},{"key":"2022061621195747300_B3","doi-asserted-by":"crossref","unstructured":"Tibbs RE, Jr., Bowles AP, Jr., Raila FA, Fratkin JD, Hutchins JB. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report. Neurosurgery\u20081997; 40: 848\u201355.","DOI":"10.1097\/00006123-199704000-00040"},{"key":"2022061621195747300_B4","doi-asserted-by":"crossref","unstructured":"Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology\u20081999; 53: 208\u201310.","DOI":"10.1212\/WNL.53.1.208"},{"key":"2022061621195747300_B5","doi-asserted-by":"crossref","unstructured":"Choo D, Shotland L, Mastroianni M, et al. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg\u20082004; 100: 480\u20137.","DOI":"10.3171\/jns.2004.100.3.0480"},{"key":"2022061621195747300_B6","unstructured":"Vortmeyer AO, Huang SC, Koch CA, et al. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors. Cancer Res\u20082000; 60: 5963\u20135."},{"key":"2022061621195747300_B7","doi-asserted-by":"crossref","unstructured":"Hamazaki S, Yoshida M, Yao M, et al. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor. Human Pathol\u20082001; 32: 1272\u20136.","DOI":"10.1053\/hupa.2001.28961"},{"key":"2022061621195747300_B8","doi-asserted-by":"crossref","unstructured":"Vortmeyer AO, Choo D, Pack SD, Oldfield E, Zhuang Z. von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst\u20081997; 89: 970\u20132.","DOI":"10.1093\/jnci\/89.13.970-a"},{"key":"2022061621195747300_B9","doi-asserted-by":"crossref","unstructured":"Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med\u20082004; 350: 2481\u20136.","DOI":"10.1056\/NEJMoa040666"},{"key":"2022061621195747300_B10","doi-asserted-by":"crossref","unstructured":"Wackym PA, Glasscock ME, III, Linthicum FH, Jr., Friberg U, Rask-Andersen H. Immunohistochemical localization of Na+, K+-ATPase in the human endolymphatic sac. Archives of Oto Rhino Laryngology\u20081988; 245: 221\u20133.","DOI":"10.1007\/BF00463931"},{"key":"2022061621195747300_B11","doi-asserted-by":"crossref","unstructured":"Ninoyu O, Meyer zum Gottesberge AM. Ca++ activity in the endolymphatic space. Archives Oto Rhino Laryngology\u20081986; 243: 141\u20132.","DOI":"10.1007\/BF00453767"},{"key":"2022061621195747300_B12","doi-asserted-by":"crossref","unstructured":"Morgenstern C, Amano H, Orsulakova A. Ion transport in the endolymphatic space. Am J Otolaryngol\u20081982; 3: 323\u20137.","DOI":"10.1016\/S0196-0709(82)80004-5"},{"key":"2022061621195747300_B13","doi-asserted-by":"crossref","unstructured":"Erwall C, Friberg U, Bagger-Sjoback D, Rask-Andersen H. Degradation of the homogeneous substance in the endolymphatic sac. Acta otolaryngol\u20081988; 105: 209\u201317.","DOI":"10.3109\/00016488809097000"},{"key":"2022061621195747300_B14","doi-asserted-by":"crossref","unstructured":"Rask-Andersen H, Stahle J. Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac. Acta otolaryngol\u20081980; 89: 283\u201394.","DOI":"10.3109\/00016488009127140"},{"key":"2022061621195747300_B15","doi-asserted-by":"crossref","unstructured":"Harris JP. Autoimmunity of the inner ear. Am J Otol\u20081989; 10: 193\u20135.","DOI":"10.1007\/978-1-349-10805-3_14"},{"key":"2022061621195747300_B16","doi-asserted-by":"crossref","unstructured":"Li JC, Brackmann DE, Lo WW, Carberry JN, House JW. Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope\u20081993; 103: 1342\u20138.","DOI":"10.1288\/00005537-199312000-00004"},{"key":"2022061621195747300_B17","unstructured":"Price EB, Jr. Papillary cystadenoma of the epididymis. A clinicopathologic analysis of 20 cases. Arch Pathol Lab Med\u20081971; 91: 456\u201370."},{"key":"2022061621195747300_B18","doi-asserted-by":"crossref","unstructured":"Pollak A, Bohmer A, Spycher M, Fisch U. Are papillary adenomas endolymphatic sac tumors? Ann Otol Rhinol Laryngol\u20081995; 104: 613\u20139.","DOI":"10.1177\/000348949510400805"},{"key":"2022061621195747300_B19","unstructured":"Bold EL, Wanamaker JR, Hughes GB, Rhee CK, Sebek BA, Kinney SE. Adenomatous lesions of the temporal bone immunohistochemical analysis and theories of histogenesis. Am J Otol\u20081995; 16: 146\u201352."},{"key":"2022061621195747300_B20","doi-asserted-by":"crossref","unstructured":"Vortmeyer AO, Yuan Q, Lee YS, Zhuang Z, Oldfield EH. Developmental effects of von Hippel-Lindau gene deficiency. Ann Neurol\u20082004; 55: 721\u20138.","DOI":"10.1002\/ana.20090"},{"key":"2022061621195747300_B21","doi-asserted-by":"crossref","unstructured":"Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol\u20082000; 157: 411\u201321.","DOI":"10.1016\/S0002-9440(10)64554-3"},{"key":"2022061621195747300_B22","doi-asserted-by":"crossref","unstructured":"Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology\u20081992; 187: 620\u20136.","DOI":"10.1016\/0042-6822(92)90464-Z"},{"key":"2022061621195747300_B23","unstructured":"Zhuang Z, Vortmeyer AO. Applications of tissue microdissection in cancer genetics. Cell Vision\u20081998; 5: 43\u20138."},{"key":"2022061621195747300_B24","unstructured":"Lo WW, Daniels DL, Chakeres DW, et al. The endolymphatic duct and sac. Am J Neuroradiol\u20081997; 18: 881\u20137."},{"key":"2022061621195747300_B25","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Sergueeva AI, Miasnikova GY, et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood\u20082004; 103: 3924\u201332.","DOI":"10.1182\/blood-2003-07-2535"},{"key":"2022061621195747300_B26","doi-asserted-by":"crossref","unstructured":"Kempermann G, Neumann HP, Volk B. Endolymphatic sac tumours. Histopathology\u20081998; 33: 2\u201310.","DOI":"10.1046\/j.1365-2559.1998.00460.x"},{"key":"2022061621195747300_B27","doi-asserted-by":"crossref","unstructured":"Pallanch JF, Weiland LH, McDonald TJ, Facer GW, Harner SG. Adenocarcinoma and adenoma of the middle ear. Laryngoscope\u20081982; 92: 47\u201354.","DOI":"10.1288\/00005537-198201000-00010"},{"key":"2022061621195747300_B28","unstructured":"Netter FH, Colacino S. Atlas of human anatomy. Summit (MJ): Ciba Geigy Corp.; 1989."},{"key":"2022061621195747300_B29","unstructured":"Williams PL. Gray's anatomy. 38th ed. New York (NY): Churchill Livingstone; 1995."},{"key":"2022061621195747300_B30","doi-asserted-by":"crossref","unstructured":"Friberg U, Rask-Andersen H, Bagger-Sjoback D. Human endolymphatic duct. An ultrastructural study. Arch Otolaryngol\u20081984; 110: 421\u20138.","DOI":"10.1001\/archotol.1984.00800330003001"},{"key":"2022061621195747300_B31","doi-asserted-by":"crossref","unstructured":"Arenberg IK, Rask-Andersen H, Wilbrand H, Stahle J. The surgical anatomy of the endolymphatic sac. Arch Otolaryngol\u20081977; 103: 1\u201311.","DOI":"10.1001\/archotol.1977.00780180039001"},{"key":"2022061621195747300_B32","doi-asserted-by":"crossref","unstructured":"Mohr VH, Vortmeyer AO, Zhuang Z, et al. Histopathology and molecular genetics of multiple cysts and microscopic (serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol\u20082000; 157: 1615\u201321.","DOI":"10.1016\/S0002-9440(10)64799-2"},{"key":"2022061621195747300_B33","doi-asserted-by":"crossref","unstructured":"Gruber MB, Healey GB, Toguri AG, Warren MM. Papillary cystadenoma of epididymis: component of von Hippel-Lindau syndrome. Urology\u20081980; 16: 305\u20136.","DOI":"10.1016\/0090-4295(80)90053-9"},{"key":"2022061621195747300_B34","doi-asserted-by":"crossref","unstructured":"Poe DS, Tarlov EC, Thomas CB, Kveton JF. Aggressive papillary tumors of temporal bone. Otolaryngol Head Neck Surg\u20081993; 108: 80\u20136.","DOI":"10.1177\/019459989310800112"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/23\/10847\/2538061\/10847-10853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/23\/10847\/2538061\/10847-10853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:33:39Z","timestamp":1655408019000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/23\/10847\/518723\/Effects-of-VHL-Deficiency-on-Endolymphatic-Duct"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":34,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2005,12,1]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-1104","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}